Role of Some Predominant Host Immunomodulators' Single Nucleotide Polymorphisms in Severity of Hepatitis B Virus and Hepatitis C Virus Infection

被引：5

作者：

Rehman, Shafiq Ur ^{[1
]}

Rauf, Mahd ^{[1
]}

Abbas, Zaigham ^{[1
]}

Hamed, Muhammed Haroon ^{[2
]}

Qadri, Ishtiaq ^{[2
]}

机构：

[1] Univ Punjab, Dept Microbiol & Mol Genet, Lahore 54590, Pakistan

[2] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia

来源：

VIRAL IMMUNOLOGY | 2016年 / 29卷 / 10期

关键词：

chronic infections; host-virus interactions; susceptibility; treatment; MANNOSE-BINDING LECTIN; NECROSIS-FACTOR-ALPHA; CHINESE HAN POPULATION; ANTIGEN CLASS-II; INTERLEUKIN-10 GENE PROMOTER; GENOME-WIDE ASSOCIATION; SPONTANEOUS VIRAL CLEARANCE; VITAMIN-D-RECEPTOR; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA;

D O I：

10.1089/vim.2016.0062

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Hepatitis B and C infections can be either acute or chronic. The chronic infection can culminate in liver cirrhosis and hepatocellular carcinoma. Influence of the host genetic makeup on conversion of acute to chronic infection, development of cirrhosis, and hepatocellular carcinoma is an interesting area of research. Variability in different immune system genes may account for such differences in the outcome of infection. This article discusses single nucleotide polymorphisms in different host immunomodulator genes that have been frequently reported to influence the outcome of infection and severity of disease. The genetic variability could be utilized for the prediction of disease outcome and treatment responses.

引用

页码：536 / 545

页数：10

共 129 条

[1] Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C [J].

Ahlenstiel, G ;

Berg, T ;

Woitas, RP ;

Grünhage, F ;

Iwan, A ;

Hess, L ;

Brackmann, HH ;

Kupfer, B ;

Schernick, A ;

Sauerbruch, T ;

Spengler, U .

JOURNAL OF HEPATOLOGY, 2003, 39 (02) :245-252

[2] Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance [J].

An, Ping ;

Thio, Chloe L. ;

Kirk, Gregory D. ;

Donfield, Sharyne ;

Goedert, James J. ;

Winkler, Cheryl A. .

JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (08) :1159-1165

[3] Interleukin-28B Genetic Variants and Hepatitis Virus Infection by Different Viral Genotypes [J].

Antonio Montes-Cano, Marco ;

Raul Garcia-Lozano, Jose ;

Abad-Molina, Cristina ;

Romero-Gomez, Manuel ;

Barroso, Natalia ;

Aguilar-Reina, Jose ;

Nunez-Roldan, Antonio ;

Francisca Gonzalez-Escribano, Maria .

HEPATOLOGY, 2010, 52 (01) :33-37

[4]

Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x

[5] Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease [J].

Asti, M ;

Martinetti, M ;

Zavaglia, C ;

Cuccia, MC ;

Gusberti, L ;

Tinelli, C ;

Cividini, A ;

Bruno, S ;

Salvaneschi, L ;

Ideo, G ;

Mondelli, MU ;

Silini, EM .

HEPATOLOGY, 1999, 29 (04) :1272-1279

[6] Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin [J].

Barrett, S ;

Ryan, E ;

Crowe, J .

JOURNAL OF HEPATOLOGY, 1999, 30 (06) :979-983

[7] Polymorphisms in tumour necrosis factor-α, transforming growth factor-β, interleukin-10, interleukin-6, interferon-γ, and outcome of hepatitis C virus infection [J].

Barrett, S ;

Collins, M ;

Kenny, C ;

Ryan, E ;

Keane, CO ;

Crowe, J .

JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (02) :212-218

[8] Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene [J].

Bellamy, R ;

Ruwende, C ;

Corrah, T ;

McAdam, KPWJ ;

Thursz, M ;

Whittle, HC ;

Hill, AVS .

JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) :721-724

[9] Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival [J].

Bellone, G ;

Smirne, C ;

Mauri, FA ;

Tonel, E ;

Carbone, A ;

Buffolino, A ;

Dughera, L ;

Robecchi, A ;

Pirisi, M ;

Emanuelli, G .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (06) :684-698

[10] The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma [J].

Berglund, M ;

Thunberg, U ;

Roos, G ;

Rosenquist, R ;

Enblad, G .

BLOOD, 2005, 105 (12) :4894-4895

← 1 2 3 4 5 6 7 8 9 10 →